Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Jefferies Downgrades Alere (ALR) to Hold Following Takeover
February 2, 2016 7:58 AM ESTJefferies downgraded Alere (NYSE: ALR) from Buy to Hold with a price target of $56.00 (from $54.00) after the company agreed to be acquired by Abbott Laboratories.
For an analyst ratings summary and ratings history on Alere... More
Raymond James Downgrades Alere (ALR) to Market Perform
February 2, 2016 7:55 AM ESTRaymond James downgraded Alere (NYSE: ALR) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Alere click here. For more ratings news on Alere click here.
Shares of Alere closed at $54.11 yesterday.
... MoreCanaccord Genuity Downgrades Alere (ALR) to Hold
February 2, 2016 7:55 AM ESTCanaccord Genuity downgraded Alere (NYSE: ALR) from Buy to Hold.
For an analyst ratings summary and ratings history on Alere click here. For more ratings news on Alere click here.
Shares of Alere closed at $54.11 yesterday.
... MoreGoldman Sachs Downgrades Alere (ALR) to Neutral
February 2, 2016 6:36 AM ESTGoldman Sachs downgraded Alere (NYSE: ALR) from Buy to Neutral with a price target of $56.00 (from $47.00).
For an analyst ratings summary and ratings history on Alere click here. For more ratings news on Alere click here.
Shares of Alere closed at $54.11 yesterday.
... MoreAbbott (ABT), Alere (ALR) Deal has $177M Termination Fee
February 1, 2016 8:37 AM ESTAbbott (NYSE: ABT) and Alere (NYSE: ALR) has a termination fee of $177 million, according to an 8-K filed with the U.S. SEC today.
... MoreUBS Remains Neutral on Abbott (ABT) Following 4Q Earnings and Conference Call
February 1, 2016 8:33 AM ESTUBS maintained a Neutral rating on Abbott Labs (NYSE: ABT), and cut the price target to $41.00 (from $43.00), following the company's 4Q earnings report. Street estimates suggested a lower 2016 outlook, driven by tougher FX in geographies where ABT has fewer natural hedges. However, the volume slowdown in oildriven economies like Venezuela took another dime or so out of the 2016 EPS... More
